Generation of soluble, catalytically active covalent HIV-1 subtype C integrase-DNA complexes to identify novel strand transfer inhibitors

Generation of soluble, catalytically active covalent HIV-1 subtype C integrase-DNA complexes to identify novel strand transfer inhibitors

Dissertation submitted to the Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, in fulfillment of the requirements for the degree of Master of Science in Medicine. Johannesburg, 2011 === The HIV-1 integrase (IN) enzyme is an integral part of the viral replication cycle a...

Full description

Bibliographic Details
Main Author:	Beyleveld, Grant James
Format:	Others
Language:	en
Published:	2014
Subjects:	HIV Integrase Inhibitors Antiviral Agents HIV Integrase
Online Access:	http://hdl.handle.net10539/13698

Similar Items

The study of susceptibility and resistance of HIV integrases to integrase strand transfer inhibitors and the development of novel single domain antibody targeting HIV integrase
by: Ni, Xiaoju
Published: (2011)

Study on suitable analysis method for HIV-1 non-catalytic integrase inhibitor
by: Ki Hoon Park, et al.
Published: (2021-01-01)

Integrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo Acids
by: Vasu Nair, et al.
Published: (2015-07-01)

HIV-1 resistance patterns to integrase inhibitors in Chilean patients with virological failure on raltegravir-containing regimens
by: Pablo Ferrer, et al.
Published: (2020-09-01)

HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
by: Pratibha C Koneru, et al.
Published: (2019-05-01)

Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors
by: Rossana Scutari, et al.
Published: (2020-03-01)

Evaluation of the NIH clinical collection to identify potential HIV-1 integrase inhibitors
by: Abrahams, Shaakira
Published: (2014)

HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana
by: Kaelo K. Seatla, et al.
Published: (2021-03-01)

Integrase-RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis
by: Jennifer L Elliott, et al.
Published: (2020-09-01)

HIV INTEGRASE INHIBITORS: THE BASIS OF EFFECTIVE AND SAFE ANTIRETROVIRAL THERAPY
by: V. I. SHAKHGILDYAN
Published: (2017-05-01)

The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity
by: Céline Amadori, et al.
Published: (2017-11-01)

Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors
by: Didier Desmaële, et al.
Published: (2010-04-01)

Resistance Analyses of Integrase Strand Transfer Inhibitors within Phase 3 Clinical Trials of Treatment-Naive Patients
by: Kirsten L. White, et al.
Published: (2014-07-01)

Molecular mechanism of HIV-1 integrase inhibition by Raltegravir proposed by using of molecular modeling approaches
by: Arora, Rohit
Published: (2012)

Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens
by: Aleksey Viktorovich Kravchenko, et al.
Published: (2010-11-01)

Modeling the HIV-1 Intasome: A Prototype View of the Target of Integrase Inhibitors
by: Robert Craigie, et al.
Published: (2010-12-01)

Identification and characterization of new cellular interacting proteins of HIV-1 integrase
by: Parvez, Md. Kamal Uddin
Published: (2011)

Identification and characterization of new cellular interacting proteins of HIV-1 integrase
by: Parvez, Md. Kamal Uddin
Published: (2011)

Evidence for Disruption of Mg2+ Pair as a Resistance Mechanism Against HIV-1 Integrase Strand Transfer Inhibitors
by: Lucas de Almeida Machado, et al.
Published: (2020-08-01)

Multiple choices for HIV therapy with integrase strand transfer inhibitors
by: Raffi Francois, et al.
Published: (2012-12-01)

Inhibition of HIV-1 integrase by [alpha]-luffin and RNA interference.
Published: (2005)

HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?
by: Vogel Martin, et al.
Published: (2009-11-01)

Pharmacokinetic drug interactions of integrase strand transfer inhibitors
by: Chi-Hua Lu, et al.
Published: (2021-01-01)

Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence
by: Thibault Mesplède, et al.
Published: (2015-07-01)

Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco
by: Najwa Alaoui, et al.
Published: (2018-06-01)

Short Communication: Integrase Strand Transfer Inhibitors Drug Resistance Mutations in Puerto Rico HIV-Positive Individuals
by: Pablo López, et al.
Published: (2021-03-01)

Structural Implications of Genotypic Variations in HIV-1 Integrase From Diverse Subtypes
by: Leonard Rogers, et al.
Published: (2018-08-01)

Prevalence of HIV-1 Integrase Strand Transfer Inhibitor Resistance in Treatment-Naïve Voluntary Counselling and Testing Clients by Population Sequencing and Illumina Next-Generation Sequencing in Taiwan
by: Tsai HC, et al.
Published: (2020-12-01)

Molecular docking study of lamellarin analogues and identification of potential inhibitors of HIV-1 integrase strand transfer complex by virtual screening
by: Chatchakorn Eurtivong, et al.
Published: (2019-11-01)

First Report of Drug Resistance against HIV-1 Integrase Inhibitors in Iran
by: Mohammad GHOLAMI, et al.
Published: (2019-04-01)

Going beyond Integration: The Emerging Role of HIV-1 Integrase in Virion Morphogenesis
by: Jennifer L. Elliott, et al.
Published: (2020-09-01)

The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75
by: Da-Wei Zhang, et al.
Published: (2020-01-01)

Mechanism of action of allosteric HIV-1 integrase inhibitors
by: Slaughter, Alison Paige
Published: (2015)

Integrase inhibitors versus efavirenz combination antiretroviral therapies for TB/HIV coinfection: a meta-analysis of randomized controlled trials
by: Yuanlu Shu, et al.
Published: (2021-05-01)

Long-Acting Anti-HIV Drugs Targeting HIV-1 Reverse Transcriptase and Integrase
by: Kamal Singh, et al.
Published: (2019-04-01)

Protéine kinase GCN2 et phosphorylation de l’intégrase du VIH-1
by: Jaspart, Anaïs
Published: (2014)

Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection
by: Abbate, I., et al.
Published: (2022)

Absence of Integrase Inhibitor-Associated Resistance Among Antiretroviral Therapy-Naïve HIV-1-Infected Adults in Guangdong Province, China, in 2018
by: Lan Y, et al.
Published: (2020-12-01)

HIV-1 Integrase-DNA Recognition Mechanisms
by: Mamuka Kvaratskhelia, et al.
Published: (2009-11-01)

Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naïve and Switch Scenarios in HIV-Infected Patients
by: Maria Saumoy, et al.
Published: (2021-08-01)